We previously showed that mast cells are important in the initiation of ocular inflammation but the exact consequences of mast cell degranulation on ocular pathology have not been characterized. We induced mast cells depletion of their inflammatory mediators by the local sub-conjunctival injection of 48/80 drug. Initial degranulation of mast cells was observed in the choroid 15 min after the injection of 48/80, with degranulation continuing to increase up to 3-6 hrs after the injection. The signs of anterior segment clinical inflammation paralleled mast cell degranulation. Posterior segment imaging using optical coherence tomography showed increased choroidal thickness and serous retinal detachments, which were confirmed by histological analysis. The infiltration of polymorphonuclear cells was associated with increased ocular media levels of TNF- at 1 and 3 hrs, followed by CXCL1, IL-6, IL-5, CCL-2 at 6 and 24 hrs, and IL-1 at 24 hrs. Analysis of levels of VEGF and IL-18 at all time intervals showed an opposite evolution of VEGF as compared to IL-18 levels suggesting that they could control each other production. These findings suggest that the local degranulation of ocular mast cells provokes acute ocular inflammation, increased choroidal vascular permeability and serous retinal detachments. The involvement of mast cells in retinal diseases should be investigated and the pharmacological inhibition of mast cells degranulation considered as a potential intervention target.
Introduction
Mast cells have been detected in the lids, conjunctiva, the uveal tract (iris, ciliary body and choroid) of several different species. 1,2,3,4, In humans and rats, mast cells are abundant in the anterior and posterior uvea but absent in the retina. 5 These cells are understood to originate from hematopoietic progenitors and following migration to vascularized tissues to mature locally. 6 Mast cells are activated by danger signals which have a specific pathogen-associated molecular pattern; exogenous signals such as lipopolysaccharide (LPS), zymosan, and peptodiglycan 7 and endogenous signals such as Interleukin-33 (IL-33), a cytokine of the IL-1 family have been shown to cause activation. 8 It is understood that the fusion of secretory granules with the plasma membrane results in the quick release of a number of cytokines and vasoactive amines such as histamine, contributing to the recruitment of neutrophils. 9 As such, mast cells initiate immune responses, in cases such as allergic disorders and immune responses to pathogens. 6, 10, 11 In the eye, degranulation of choroidal mast cells has been shown to contribute to the early onset of Experimental Autoimmune Uveoretinitis (EAU) 4, 12 and of Endotoxin Induced Uveitis (EIU). 13, 14 On the other hand, the depletion of mast cells from their inflammatory mediators with the compound 48/80 was shown to prevent EAU development. 12 Moreover, topical ocular medications designed to block mast cell degranulation have been reported to decrease the clinical severity of the disease during EAU. 12 Serous retinal detachments (SRD) which are almost always observed during EAU are often observed in eyes with ocular inflammatory disorders such as Vogt-Koyanagi-Harada disease. 15 However there may be multiple mechanisms leading to SRD, as they also are present in other ocular disorders such as central serous chorioretinopathy and wet Age related Macular Degeneration (AMD). 16 In AMD for
example, genetic studies have demonstrated that complement alternative pathway activation is associated with increased prevalence of the disease. 17, 18, 19 Deposits of C5a, a potent mast cells degranulating component, 20 have been detected in the choroid and retinal pigment epithelium of eyes with AMD, 21 suggesting that mast cells may be a complement pathway effector in AMD pathogenesis.
In order to clarify the direct role of mast cells in ocular pathology, we examined the effects of specific ocular mast cells degranulation in rats by the local unilateral subconjunctival injection of the synthetic compound 48/80.
Materials and Methods

Animals
Adult female Lewis rats (6-8 weeks old, Janvier, Le Genest-Saint-Isle, France) were used in this study. Animals were housed in a 12-hrs light and 12-hrs dark cycle and fed water and dried ration ad libitum. Experimental procedures were submitted and approved by the ethic committee of Paris Descartes University (number: Ce5/2012/122 pyrogen-free saline), was performed in the right eye in the temporal site of the conjunctiva as previously described 12 using 1 mL syringes with 30G needle. Left eye was not injected.
-Subconjunctival administration of NaCl: Control rats were injected subconjunctivally with vehicle (NaCl 0.9%).
-Subconjunctival injection of disodium cromoglycate: Disodium cromoglycate (DSCG, cromolyn sodium salt, Sigma-Aldrich) blocks the release of mediators from mast cells. 6 One subconjunctival injection of DSCG (2 mg DSCG/rat weighing 200 g dissolved in 100 L saline) was administered at the nasal site 15 min before the subconjunctival administration of compound 48/80 performed at the temporal site.
In vivo investigations
Clinical examination
Eyes were examined with a biomicroscope (slit lamp) at regular time intervals in 48/80-injected eyes, in contralateral non-injected eyes and in eyes from the group injected with DSCG i.e. 10-30 min, 1, 2, 3, 4, 5, 7, 24 hrs after 48/80 subconjunctival injection. At each time point, the conjunctiva, lens, iris and pupil and the anterior chamber were observed.
Pupillary dilation was obtained after administration of a drop of mydriaticum (Thea, Clermont
Ferrand, France). The severity of the reaction to the subconjunctival injection of 48/80 took into account each ocular inflammatory sign: -conjunctival edema, -vasodilation of iris vessels, 5 myosis, -fibrin exudate, -hypopion, -iris haemorrhages, -synechiae. Presence of each sign was encoded as 1, absence as 0, the severity of the response was evaluated in each eye by the sum of the pathological signs/eye. Alteration of the lens transparency (cataract) was also evaluated.
Optical Coherence Tomography (OCT)
The assessment of rat retina and choroid was performed on anesthetized animals using spectral domain optical coherence tomography (SD-OCT, Spectralis™ device, Heidelberg, Germany) adapted for small animal eyes. 22 Pupils were dilated with 5% tropicamide drops.
Scans were taken in the same rats prior to treatment and at 1, 3, 6 and 24 hrs after 48/80 subconjunctival injection. Each two-dimensional B-scan recorded at 30° field-of-view consisted of 1536 A-scans with an optical resolution reaching 3.5 μm and the enhanced depth imaging option (EDI) was used to evaluate the choroidal thickness.
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Ex vivo investigations
Experimental groups of rat eyes were as follows: 48/80-injected eyes, contralateral noninjected eyes and NaCl-injected eyes, enucleated at 4 time points after 48/80 injection at namely 1 hr, 3 hrs, 6 hrs and 24 hrs. Number of experimental eyes are indicated in figure legends.
Flat-mounted preparations of the choroid (as previously described 4 Staining that omitted the primary antibody served as negative control.
Histological sections for the assessment of ocular pathology and choroidal thickness
Eyes were fixed in 0.5% glutaraldehyde / 4% paraformaldehyde (PFA) for 2 hrs, dehydrated in a graded alcohol series (50%, 70%, 95% and 100%) and embedded in epoxy resin, 5 m section were cut and stained with toluidine blue. The morphology and pathological modifications of ocular tissues were examined under a light microscope (DM5500B, Leica, Nanterre, France).
Choroidal thickness was measured (ImageJ) on photographs taken on historesin sections from the optic nerve to the ciliary body. Each measurement was taken at 300 m on each side of the optic nerve 25 of 48/80-injected eyes, contralateral non-injected eyes and NaCl-injected eyes.
TUNEL assay
Enucleated eyes were snap frozen in Tissue-Tek OCT-compound (Bayer Diagnostics, 
Statistics
Data were expressed as means ± SD. Statistical analysis was made using the Graphpad Prism5 program (Graphpad Software, San Diego, CA, USA). A Mann Whitney test was used for comparison between two groups and comparisons more than two groups were performed using one-way ANOVA test followed by Bonferroni's comparison, significance was investigated at the 5% level for all test types.
Results
Subconjunctival injection of 48/80 induces clinical ocular inflammation
Biomicroscope (slit lamp) examination was performed at different time intervals after 48/80 or saline injection. Unilateral clinical signs of ocular inflammation were observed ( In the eyes where mast cell mediator release inhibitor DSCG was injected 15 min prior to 48/80, no clinical signs of inflammation were observed (not shown).
Morphological modifications and quantification of mast cells in choroid flat mounts.
The morphology of choroidal mast cells was analysed using flat mounts preparations (Fig. 2 ).
Mast cells are regularly located around large choroidal vessels. In left non-injected eyes ( Compared to contralateral non-injected eyes, the number of degranulated mast cells was significantly higher at 1 hr and 3 hrs in 48/80 injected eyes (Fig. 2 G) . Correlatively, significantly lower number of non-degranulated mast cells was found in 48/80-injected eyes compared to non-injected eyes (Fig. 2 H) .
Ocular pathology induced by mast cells degranulation
Pathological modifications of ocular tissues were evaluated in historesin sections. In left noninjected eyes, mast cells showed a normal resting shape (Fig. 3, A, C) , at the vicinity of vessels at the limbus of the cornea (Fig. 3 A, insert) and also in the choroid (Fig. 3 C, insert) .
In the right 48/80-injected eyes, at 1 and 3 hrs, degranulated mast cells were observed in the vicinity of vessels at the limbus of the cornea (Fig. 3 D, insert ) and in the conjunctiva ( Fig. 3 9 E, insert). In these eyes, mast cell degranulation in the anterior segment was associated with intense infiltration of PMNs (Fig. 3 F , insert, arrowhead) and macrophages ( Fig. 3 F , insert, arrow) at 3 hrs to persist up to 24 hrs, and with alterations of corneal endothelial cells (Fig. 3 F, asterisk). In the posterior segment, mast cell degranulation was associated with fibrin exudate above the RPE in the subretinal space (Fig. 3 G, arrow) together with choroidal vessel dilation (Fig. 3 G, asterisk) . Moreover, exudative retinal detachments appeared in the same locations as moderate to extensive ruptures of the RPE barrier and important retinal folds ( Fig. 3 G and 3 H) .
Starting at 1 hr (Fig. 3 G) after 48/80 injection to be very important at 3 hrs-24 hrs (Fig. 3 H) , alterations of the retinal nuclear cell layers with picnotic aspects of the nuclei of photoreceptors and bipolar cells visible at the level of the retinal detachment. At 24 hrs, detachments and large destructions of the retina were observed (Fig. 3 H) . Numerous TUNEL-positive nuclei were detected at 3 hrs (Fig 3 J) and at 24 hrs (Fig. 3 K) , in the three nuclear cell layers, aspects consistent with the pathological aspect of retinal cells shown in historesin section (Figure 3 H) .
OCT examination of posterior segment of the eye
One hour post 48/80 injection, the retina presented undulations, the apex of which were hyper reflective ( Fig. 4 A, B, arrows) . From 3 hrs to 24 hrs after 48/80 subconjunctival injection, larger and multiple retinal serous detachments were observed (Fig. 4 D, E, G, F) with pockets of subretinal fluid (Fig. 4 D, E, G, F, stars) . Detachments of the neuroretina, due to subretinal accumulation of material were observed on histological section (Fig. 4 C, arrow) . Edema was located in the retinal nuclear cell layers (Fig. 4 C, F, arrowheads ). An increase of the choroidal thickness (Fig. 4 H, I , arrowheads) was observed related to dilation of the choriocapillaris (Fig 4 I star) and large choroidal vessels (Fig 4 I asterisk) . No pathological changes were observed in contralateral non-injected eyes.
Increase of choroidal thickness in 48/80-injected eyes
At 1-3 hrs, compared to choroidal thickness in the left non-injected eyes and in NaCl-injected eyes, a significant and localized increase of choroidal thickness was detected in right 48/80-injected eyes (Fig. 5 A, B) . At 6 -24 hrs, the choroidal thickness increase extended also to the periphery and all over the choroid surface (Fig. 5 C, D) .
RPE barrier breakdown induced by mast cell degranulation
RPE flat mount were used to visualize the RPE cells junctions at 1 hr after 48/80 injection. In NaCl and contralateral non-injected eyes, occludin labelled a regular hexagonal membrane of the RPE cells (Fig. 4 A) . In 48/80-injected eyes, an abnormal shape in some RPE cells with irregular occludin labelling ( Fig. 4 B, arrowhead) was observed. In particular RPE cells defects (Fig. 4 B, C, stars) and localized enlargement of intercellular space (Fig. 6 D, arrowhead) were present throughout.
Close examination of historesin sections, showed a regular interface between the RPE cell monolayer and Bruch's membrane in contralateral non-injected eyes (Fig. 4 E, arrows) , whereas in 48/80-injected-eyes, large alterations of the RPE were detected at all time points, in locations adjacent to the choriocapillaris (Fig. 6 F asterisk) . RPE cells detached from the basal membrane and migrated, in either isolated or as large sheets of RPE, into the subretinal space ( Fig. 4G, arrowhead) . These round, binuclearly detached cells, allowed the positive identification of the RPE cells (Fig. 4 G) .
Effect of mast cells degranulation by compound 48/80 on ocular cytokine and chemokine concentrations in ocular fluids
Multiplex ELISA analysis showed that the level of several inflammatory mediators was significantly higher in 48/80-injected eyes compared to control NaCl-injected eyes (Fig. 7) .
As early as 1 hr after 48/80 injection, TNF- was significantly increased as compared to NaCl-injected eyes (Fig. 7 A) . This increase persisted at 3 hrs, but not at 6 hrs. A significantly increased level of IL-5 was observed at 3 hrs, 6 hrs and 24 hrs (Fig. 7 B) , together with significantly increased levels of IL-6 and CCL-2 at 6 hrs and 24 hrs (Fig. 7 C, D) .
Furthermore a significant increase of IL-1, CXCL-1 and IL-18 was observed at 24 hrs ( Fig.   7 E, F, G) while significant decrease of VEGF occurred at this time (Fig. 7 I) . Levels of IL-18 ( Fig. 7 H) and VEGF (Fig. 7 J) mirrored each other suggesting co-regulation. The cytokine levels in the contralateral non-injected eyes were consistent with levels found in NaCl eyes. 31 and induce the synthesis of TNF- and IL-6. 32 In the present study, TNF-, was the first cytokine to be up regulated in the eye (1 hr after 48/80 injection), followed by IL-6 (6 hrs), confirming that TNF- could be an inducer of IL-6 release during ocular inflammation. 33 It is understood that TNF- can contribute to the outer retinal barrier breakdown, as rat RPE cell monoculture co-incubated with TNF- together with LPS+IFN- altered RPE tight junctions with abnormal distribution of ZO-1. recruit neutrophils through TNF- release. 35 The injection of HrIL-6 (Human recombinant IL-6) into the vitreous has been reported to induce an accumulation of neutrophils in the anterior and posterior segments of the eye. 36 Further, in the present situation, the rat chemokine CXCL-1 (a neutrophil chemoattractant) was also significantly increased and responsible, together with TNF- and IL-6, for the neutrophils infiltration of the anterior chamber. Combined, these different mediators, successively produced, created the structure to allow the neutrophil infiltration observed after 48/80 injection in study eyes. Further, IL-18, a potent neutrophil-activating factor, 37,38 was augmented after 48/80 injection with an opposite regulation of the levels of VEGF. At 24 hrs, significantly higher levels of IL-18 and lower levels of VEGF were observed in 48/80-injected rats as compared to contralateral eyes. The exact role of IL-18 in the eye is still unclear 39 but VEGF and IL-18 were shown to suppress each other's production. 40 In a mouse model of neovascularization, 41 IL-18 inhibited new vessel formation but promoted damages to the RPE that mimics aspects of the dry form of AMD. 42 Alteration of RPE cells after mast cell degranulation could thus be at least in part related to IL-18 increase.
This study shows for the first time that mast cells degranulation induces choroidal, RPE and retinal pathology resulting in serous retinal detachment, a sign common to various retinal diseases. Development of spectral-domain OCT using enhanced depth imaging module has allowed to identify a wide spectrum of chorioretinal diseases associated with pachychoroid
13
(choroidal thickening) such as central serous chorioretinopathy and polypoidal choroidal vasculopathy. 43 Whether mast cell degranulation could be involved in such conditions should be explored. The fact that mast cells progressively reconstitute their granules evokes that if the stimulus persists, successive degranulations could lead to chronic barriers breakdown and sub-retinal fluid accumulation. In AMD, complement activation leads to C5a accumulation in the choroid, which could also induce mast cells degranulation 21 contributing to exudative complications.
In conclusion, since factors that trigger or result from mast cell degranulation have been identified in the pathogenesis of many "a priori" non-inflammatory diseases, including AMD, we suggest that mast cell degranulation could be an important factor in chronic ocular Data are means ± SEM, n = 3 rats per condition, * p<0.05. Retinal sections were immunostained by TUNEL assay (green) and DAPI (blue) (I-K).
Normal retina was observed in the left non-injected eye (I). In contrast apoptotic retinal cells showed a localized significant increase of thickness compared to contralateral eyes (n = 6) and NaCl-injected eyes (n =5). C, D. At 6 hrs and 24 hrs, a significant and extended increase of choroidal thickness was shown in choroids from rats injected with 48/80 (n = 6) compared to contralateral eyes (n = 6) and NaCL-injected eyes (n = 6). hr, whereas VEGF significantly increased compared to its levels at 1 hr. In contrast compared to levels at 3 hrs, at 6 hrs and 24 hrs IL-18 significantly increased whereas VEGF significantly decreased.
48/80-injected eyes: n = 4-6 per time point; NaCl-injected eyes (control) : n = 5-6 per time point
